
INTERPHEX Week Tokyo consists of 6 exhibitions for pharmaceutical technologies - INTERPHEX JAPAN (Manufacturing & Packaging), in-PHARMA JAPAN (APIs/ Pharmaceutical Ingredients), BioPharma Expo (Biopharmaceutical), PharmaLab Tokyo (Drug Discovery), PharmaDigital Transformation Expo (Digital Transformation Technology & Services for Pharmaceutical Industry) and CMO/CDMO Expo.
Key Considerations and Challenges in Scalable Manufacturing of Stem Cell-Based Therapeutics
~ From iPSC Expansion to Differentiation ~
Time: May 20, 15:00–15:30
Location: Exhibitor Seminar Room 2 (Hall 1)
Presentation Overview
This presentation discusses strategies to support scalable manufacturing of induced pluripotent stem cell (iPSC)-based therapies. It highlights the role of GMP-compliant extracellular matrix proteins, including Laminin 521 and Laminin 511, in enabling efficient iPSC expansion and controlled differentiation. The talk will also cover process development considerations and functional validation of iPSC-derived cell products such as NK cells.




